A US Multicenter Collaborative Study on Outcomes of Hematopoietic Cell Transplantation in Hepatosplenic T-Cell Lymphoma

Hepatosplenic T-cell lymphoma (HSTCL) is an extremely rare subtype of non-Hodgkin lymphoma (NHL) accounting for less than 1% of cases.1-3 HSTCL was first described in 1981 and included as a provisional entity in the revised European-American classification of lymphoid neoplasms in 1994.4,5 Subsequently, HSTCL was recognized as a separate entity in the World Health Organization (WHO) classification of lymphoid malignancies in 1999.6

Source: Biology of Blood and Marrow Transplantation - February 29, 2024 Category: Hematology Authors: Muhamad Alhaj Moustafa, Jeremy L Ramdial, Athanasios Tsalatsanis, Farhad Khimani, Bhagirathbhai Dholaria, Leyla Bojanini, Taylor Brooks, Jasmine Zain, N. Nora Bennani, Zachary Braunstein, Jonathan E. Brammer, Amer Beitinjaneh, Deepa Jagadeesh, Wen Kai Wen Source Type: research